These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17450340)

  • 21. Routine use of HSV-1 and HSV-2 antibody testing.
    Nahmias AJ
    Herpes; 2002 Dec; 9(3):83. PubMed ID: 12470607
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.
    Manickan E; Kanangat S; Rouse RJ; Yu Z; Rouse BT
    J Leukoc Biol; 1997 Feb; 61(2):125-32. PubMed ID: 9021916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?
    Noisakran S; Carr DJ
    Immunol Res; 2001; 24(1):1-11. PubMed ID: 11485206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of famciclovir for prevention of herpetic whitlow in the health care setting.
    Manian FA
    Clin Infect Dis; 2000 Oct; 31(4):E18-9. PubMed ID: 11049807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex: insights on pathogenesis and possible vaccines.
    Koelle DM; Corey L
    Annu Rev Med; 2008; 59():381-95. PubMed ID: 18186706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders.
    Gentile I; Zappulo E; Bonavolta R; Maresca R; Riccio MP; Buonomo AR; Portella G; Vallefuoco L; Settimi A; Pascotto A; Borgia G; Bravaccio C
    In Vivo; 2014; 28(4):667-71. PubMed ID: 24982239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
    Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Herpes simplex virus type 1 and 2].
    Yoshida M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():306-9. PubMed ID: 20942065
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?".
    Royer DJ; Carr DJJ
    J Virol; 2017 Dec; 91(23):. PubMed ID: 29138328
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
    Bradley H; Markowitz LE; Gibson T; McQuillan GM
    J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
    Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical uses of herpes simplex virus type-specific serology.
    Munday PE; Mullan HM
    Int J STD AIDS; 2001 Dec; 12(12):784-8. PubMed ID: 11779367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic tests: Herpes simplex virus type 1 and 2].
    Yoshida M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():291-3. PubMed ID: 16111253
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
    Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
    Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early acquisition of herpes simplex virus type 1 antibodies in children--a longitudinal serological study.
    Tunbäck P; Bergström T; Claesson BA; Carlsson RM; Löwhagen GB
    J Clin Virol; 2007 Sep; 40(1):26-30. PubMed ID: 17644470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for diagnostic screening of Herpes simplex virus in patients with nongonococcal urethritis.
    Madeb R; Nativ O; Benilevi D; Feldman PA; Halachmi S; Srugo I
    Clin Infect Dis; 2000 Jun; 30(6):982-3. PubMed ID: 10880323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of HSV-1, HSV-2 infection].
    Ando Y
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():226-9. PubMed ID: 16615472
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine?
    Juhl D; Mosel C; Nawroth F; Funke AM; Dadgar SM; Hagenström H; Kirchner H; Hennig H
    Transfus Med; 2010 Feb; 20(1):38-47. PubMed ID: 19708895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.